Mirum Pharmaceuticals (MIRM) revenue and earnings history
Mirum Pharmaceuticals reported revenue of $521M for fiscal 2025 (year ended Dec 31, 2025), +54.7% on the year before, and net income of −$23.4M.
Revenue and net income, 7 fiscal years
Annual figures, newest first
| Fiscal year | Revenue | Operating income | Net income | Operating cash flow | Capital expenditure | Free cash flow | Stock-based pay | Share buybacks | Dividends paid | Cash at year end | Total debt at year end | Report |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025ended Dec 31, 2025 | $521M+54.7% | −$22.1M | −$23.4M | $55.8M | $954K | $54.9M | $71.4M | — | — | $297M | — | 10-K |
| 2024ended Dec 31, 2024 |
The latest quarter, insider trades and fund moves: Mirum Pharmaceuticals (MIRM) on OQRO.
Common questions
What was Mirum Pharmaceuticals's revenue in fiscal 2025?
$521M for the year ended Dec 31, 2025, as reported in its 10-K filed Feb 25, 2026. That is +54.7% on fiscal 2024 ($337M).
Has Mirum Pharmaceuticals been profitable?
It reported a net loss in 7 of the years shown (2019, 2020, 2021, 2022, 2023, 2024, 2025). The highest net income was −$23.4M in fiscal 2025.
What was Mirum Pharmaceuticals's free cash flow in fiscal 2025?
$54.9M: operating cash flow of $55.8M minus capital expenditure of $954K. OQRO calculates free cash flow this way from the two filed lines.
Where these figures come from
The SEC’s companyfacts data: every figure Mirum Pharmaceuticals tagged in XBRL in its annual and quarterly reports since 2009 (some reports carry a few earlier years as comparatives). For each fiscal year OQRO keeps the twelve-month totals from the annual report and the cash and debt at year end, and when a later report restates a year, the later figure. Read again whenever the company files.
Figures are as reported, in US dollars, with no adjustment for acquisitions, disposals or one-off items. Earnings per share are left out because a stock split changes them between reports. This page describes the past and is not investment advice. No language model wrote it.
